tradingkey.logo
tradingkey.logo
Search

Bicara Therapeutics Inc

BCAX
Add to Watchlist
27.100USD
+0.830+3.16%
Close 07-31 16:00ETQuotes delayed by 15 min
1.78BMarket Cap
LossP/E TTM

BCAX Financials

See Bicara Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Bicara Therapeutics Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-0.93/-0.75
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.52
37.64%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
Financial Indicators
EPS
-36.83%-0.93
78.72%-0.68
-107.24%-0.67
---0.50
96.43%-0.68
---3.19
27.21%-0.32
----
---18.94
----
---0.44
----
----
----
Net Profit
-52.56%-56.21M
-78.39%-37.39M
-107.83%-36.33M
---27.39M
-194.58%-36.85M
---20.96M
23.48%-17.48M
----
---12.51M
----
---22.84M
----
----
----
Operating profit
-44.16%-60.24M
-54.38%-41.12M
-97.19%-40.68M
---32.02M
-171.81%-41.79M
---26.64M
-116.45%-20.63M
----
---15.37M
----
---9.53M
----
----
----
Net Profit
-52.56%-56.21M
-78.39%-37.39M
-107.83%-36.33M
---27.39M
-194.58%-36.85M
---20.96M
23.48%-17.48M
----
---12.51M
----
---22.84M
----
----
----
Current assets
15.75%544.91M
-16.01%422.05M
-42.98%297.37M
115.64%444.39M
--470.75M
--502.53M
--521.51M
--206.08M
----
----
----
----
----
----
Total current liabilities
105.75%39.34M
60.92%28.95M
45.21%21.03M
7.23%17.23M
--19.12M
--17.99M
--14.48M
--16.07M
----
----
----
----
----
----
Total assets
15.80%553.60M
-15.49%430.99M
-18.98%424.69M
117.25%453.59M
--478.08M
--510.00M
--524.17M
--208.78M
----
----
----
----
----
----
Total liabilities
107.33%39.64M
63.03%29.54M
49.87%21.91M
12.95%18.39M
--19.12M
--18.12M
--14.62M
--16.28M
----
----
----
----
----
----
Total equity
11.98%513.96M
-18.38%401.45M
-20.95%402.78M
126.07%435.20M
--458.96M
--491.88M
--509.56M
--192.50M
----
----
----
----
----
----
Net operating income
-33.45%-37.51M
20.46%-23.89M
-69.81%-29.25M
---25.59M
-92.68%-28.11M
---30.03M
-63.54%-17.22M
----
---14.59M
----
---10.53M
----
----
----
Net investment
--100.94M
-205730.00%-82.33M
-2951412.50%-236.12M
--0.00
-100.00%0.00
---40.00K
94.67%-8.00K
----
--58.00K
----
---150.00K
----
----
----
Net financing
35409.78%163.34M
3303.08%31.23M
-99.87%436.00K
--135.00K
235.77%460.00K
---975.00K
737.39%334.13M
----
--137.00K
----
--39.90M
----
----
----

FAQs

What are the current assets of Bicara Therapeutics Inc?

According to Bicara Therapeutics Inc's FY2025 earnings report, its current assets were 422.05M, with a year-on-year change of -16.01.

What are the total assets of Bicara Therapeutics Inc?

According to Bicara Therapeutics Inc's FY2025 earnings report, its total assets of Bicara Therapeutics Inc were 430.99M, with a year-on-year change of -15.49.

What are the total liabilities of Bicara Therapeutics Inc?

According to Bicara Therapeutics Inc's FY2025 earnings report, its total liabilities of Bicara Therapeutics Inc were 29.54M, with a year-on-year change of 63.03.

What is the total equity of Bicara Therapeutics Inc?

According to Bicara Therapeutics Inc's FY2025 earnings report, its total equity of Bicara Therapeutics Inc was 401.45M, with a year-on-year change of -18.38.

What is the net operating income of Bicara Therapeutics Inc?

According to Bicara Therapeutics Inc's FY2025 earnings report, its net operating income of Bicara Therapeutics Inc was -155.60M, with a year-on-year change of -88.87.

What is the net investment of Bicara Therapeutics Inc?

According to Bicara Therapeutics Inc's FY2025 earnings report, its net investment of Bicara Therapeutics Inc was -318.45M, with a year-on-year change of -3538266.67.

What is the net financing of Bicara Therapeutics Inc?

According to Bicara Therapeutics Inc's FY2025 earnings report, its net financing of Bicara Therapeutics Inc was 32.26M, with a year-on-year change of -90.34.

What is the Earnings Per Share (EPS) of Bicara Therapeutics Inc?

According to Bicara Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.52, with a year-on-year change of 37.64.

What is the net income of Bicara Therapeutics Inc?

According to Bicara Therapeutics Inc's FY2025 earnings report, its net income was -137.95M, with a year-on-year change of -102.88.

What is the Return on Equity (ROE) of Bicara Therapeutics Inc?

According to Bicara Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -30.88, with a year-on-year change of 22.08.

What is the Return on Assets (ROA) of Bicara Therapeutics Inc?

According to Bicara Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -29.32, with a year-on-year change of -60.41.

What is the operating profit of Bicara Therapeutics Inc?

According to Bicara Therapeutics Inc's FY2025 earnings report, its operating profit was -155.60M, with a year-on-year change of -88.87.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.